[Modern view points on the therapy of urogenital tuberculosis].
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002207:Capreomycin / Q000627:therapeutic use; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009392:Nephrectomy; D012293:Rifampin / Q000627:therapeutic use; D014401:Tuberculosis, Urogenital / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000995:Antitubercular Agents; D002207:Capreomycin; D004977:Ethambutol; D012293:Rifampin
Moderne Gesichtspunkte in der Therapie der Urogenitaltuberkulose.